Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-676-4 | CAS number: 68603-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Fd Chem. Tox. Vol 31, No 12. Year 1993
- Author:
- Webb D.R., Wood F.E., Bertram T.A. and Fortier N.E.
- Year:
- 1 993
- Bibliographic source:
- Fd Chem. Tox. Vol 31, No 12. Year 1993
- Reference Type:
- publication
- Title:
- Estimation of NOAEL values for fatty acids from Caprenin rat feeding experiments
- Author:
- Hillesheim W
- Year:
- 2 014
- Bibliographic source:
- GUBDH Consultancy
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Caprenin
- IUPAC Name:
- Caprenin
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): caprenin
- Molecular formula (if other than submission substance): triglyceride; fatty acid composition
Fatty acid composition of Caprein, MCT, and vehicle corn oil (% w/w) (Webb et al. 1993)
Fatty acid Caprenin Corn oil MCT
C6:0 - - 4.5
C8:0 23.2 - 70.6
C10:0 26.6 - 25.9
C12:0 0.3 - -
C16:0 0.2 11.3 -
C18:0 0.9 2.1 -
C18:1 - 25.4 -
C18:2 - 60.7 -
C18:3 - 0.5 -
C20:0 2.7 - -
C22:0 45.0 - -
C24:0 1.1 - -
- Molecular weight (if other than submission substance): approx. ; calculated from fatty acid composition
- Substance type: triglyceride
- Physical state: no data
- Analytical purity: analytical results see table above
- Impurities (identity and concentrations): analytical results see table above
- Composition of test material, percentage of components: analytical results see table above
- Stability under test conditions: no data; fresh diets were prepared weekly
- Storage condition of test material: no data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Inc., Raleigh, NC, USA
- Age at study initiation: approx 4weeks
- Weight at study initiation: males 85 (71-98) g; females 78 (68-88) g
- Fasting period before study: no
- Housing: two per cage
- Diet: ad libitum;
Control diets: corn oil (12.1%); MCT (11.21%)
Test article: Caprenin 5.23%, 10.23%, and 15.0%
Al diets prepared to provide about 4000 kcal/kg
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 50 +/- 20
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: receipt of animals 5 days prior to study To: Day 91 of study
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: semi-purified corn oil control diet (min3% corn oil; contained mineral an dvitamine mix, carbohydrates, protein; publication table 4)
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
DIET PREPARATION
- Rate of preparation of diet (frequency): weeks
- Mixing appropriate amounts with (Type of food): semi-purified diet a sdescribed above
- Storage temperature of food: refrigerated. Freshly diet was placed in glass jars twice weekly.
- Stability: less than 0.03% free fatty acid and 1.4 mEq peroxide was initially contained in caprenin, MCT and corn oil. No increase was not during 91 days of bulk refrigerated storage, nor in diets held for up to 7 days at room temperature.
VEHICLE
- Justification for use and choice of vehicle (if other than water): diet is the vehicle of choice in feeding studies
- Concentration in vehicle: 5.23, 10.23, and 15.0% (w/w)
- Purity: cf. publication, tables 3 and 4 - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 91 days
- Frequency of treatment:
- 7 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
5.23, 10,23, 15% (w/w)
Basis:
nominal in diet
- No. of animals per sex per dose:
- 25
- Control animals:
- yes, concurrent vehicle
- other: MCT 11.21%
- Details on study design:
- - Dose selection rationale: 0, 5, 10, and 15% caprenin was used in a preceeding 28-day rat study (both sexes) where the NOAEL was 15% in the diet.
- Rationale for animal assignment (if not random): n.a.
- Rationale for selecting satellite groups: n.a.
- Post-exposure recovery period in satellite groups: n.a.
- Section schedule rationale (if not random): n.a. - Positive control:
- MCT 11.21%
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: weekly
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Yes
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes / No / No data
- Time schedule for examinations:
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: prior to study and at week 13
- Dose groups that were examined: no data
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at end of study
- Anaesthetic used for blood collection: Yes (CO2/O2 mix)
- Animals fasted: Yes
- How many animals: 20 per sex/group
- Parameters examined: leucocyte count, corrected leucocyte count, leucocyte differential, erythrocyte count, haemoglobin, haematocrit, platelet count, cell morphology, absolute reticulocyte count, mean cell volume, mean cell haemoglobin, and mean cell haemoglobin concentration, prothrombin time.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at termination
- Animals fasted: Yes / No / No data
- How many animals: 20/sex/group
- Parameters examined: Sodium potassium, chloride, calcium, inorganic phosphorus, glucose, total bilirubin, blood urea nitrogen (BUN), total protein, albumin, globulin, creatinine, total cholesterol, lipoproteins, triglycerides, gamma-glutamyltransferase (GGT), alkaline phosphatase (AP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT)
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No
OTHER: behenic acid (C22:0) content in heart, liver, perirenl fat tissue. 5 rats per sex/group - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
Organ weights: liver, kidneys, brain, adrenals, spleen, heart, colon, caecum, testes, ovaries
HISTOPATHOLOGY: Yes; no list provided . liver, heart, kidneys, , bone marrow, possibly more organs (see above) - Other examinations:
- content of C22:0 acid in fat from heart, liver, and perirenal fat
- Statistics:
- ANOVA, Bartlett's test, t-.test, Wilcoxon rank sum test. Fisher-Irwin exact test.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No clinical signs noted. One corn oil control male and one high-dose female died in wk 6 an wk 8 respectively. Deaths were not related to treatment.
- Mortality:
- no mortality observed
- Description (incidence):
- No clinical signs noted. One corn oil control male and one high-dose female died in wk 6 an wk 8 respectively. Deaths were not related to treatment.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- no statistical significant diferences in body weight gain at termination
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- in both sexes increased with caprenin dose, compared to corn oil and MCT controls
- Food efficiency:
- effects observed, treatment-related
- Description (incidence and severity):
- decreased in both sexes at the top caprenin dose, compared with corn oil and MCT controls
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- marginal changes were seen
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- several statistical significant changes, but mild with no toxicological relevance
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- relative colon weight stat. signif. increased in both sexes, but not considered to be of toxicological relevance
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- significantly increased number of granular/rough kidneys in high dose females (9/20) compared to corn oil controls (9/20). No histopathological correlate noted.
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- Liver vacuolisation in all treated and control rats; considered as a common finding in rats maintained at high-fat, semi-purified diets. Nephrocalcinosis was also seen in all rats, but histopathology revealed no treatment-relationship
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No clinical signs noted. One corn oil control male and one high-dose female died in wk. 6 an wk. 8 respectively. Deaths were not related to treatment.
BODY WEIGHT AND WEIGHT GAIN
no statistical significant differences in body weight gain across groups at termination.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
in both sexes increased with caprenin dose, compared to corn oil and MCT controls
FOOD EFFICIENCY
decreased in both sexes at the top caprenin dose, compared with corn oil and MCT controls. This was considered to reflect that the caprenin diets was not isocaloric with the corn oil and MCT control diets, due to an incomplete absorption of behenic acid. Further, poor absorption also considered to cause increased colon weights in caprenin groups (see below).
OPHTHALMOSCOPIC EXAMINATION
No effect in either group
HAEMATOLOGY
Few small isolated changes were noted. Serum haemoglobin of mid (+4%) and high-dose males were significantly higher than that of corn oil controls. Relative to MCT oil, mean cell volume was significantly greater in low (+2%) and mid-dose (+2%) males, mean cell haemoglobin was greater in all treated males (range of +2 to +3%), and activated partial thromboplastin time was greater in high-dose males (+9%). Platelet count was higher (+10%) with MCT oil relative to corn oil.
All these differences were considered to be minor and unrelated to treatment since they fell within the normal historical range for rats of this sex and strain.
CLINICAL CHEMISTRY
Caprenin treatment: several parameters were statistically significantly changed compared to corn oil or MCT controls. However, most of these changes were generally mild, showed no dose-relationship, and occurred inconsistently between sexes. As there were no other findings including histopathology, and because the changes were close to or within the historical range, the changes were not considered to be of toxicological relevance. Examples of such observations included glucose, total cholesterol, LDL, HDL, triglycerides, potassium calcium, chloride, AST.
MCT treatment: similarly, several statistically significant changes were noted compared to corn oil controls. Examples include glucose, AP, total protein, albumin, phosphorous, calcium, and triglycerides. With the exception of triglycerides the magnitude was generally low and within the historical control range. Hence, the changes were not considered to represent toxicological responses.
URINALYSIS no data
NEUROBEHAVIOUR no data
ORGAN WEIGHTS
Statistically significant changes in absolute or relative organ weights compared to corn oil controls or MCT controls were only seen in the liver, colon, kidneys, heart, and spleen. The three latter changes were mild, restricted to relative organ weights only, were unrelated to treatment and were, therefore, not considered to be related to treatment. There was a tendency of lower liver weights with increasing caprenin dose. The effect was small and gained statistical significance dose especially in males. Significantly higher relative colon weights were seen in males and females whereas absolute weight was significantly higher only in mid- and high-dose males. These changes were all small, lacked a relationship to treatment, were inconsistent to sex, and lacked a histopathological correlate. Hence, the observations lack toxicological relevance.
The weight of testes and ovaries was not changed by any treatment.
GROSS PATHOLOGY
A significantly increased number of granular/rough kidneys in high-dose caprenin females (9/20) compared to corn oil controls (9/20) was noted. As there was no histopathological correlate, this was not considered to be adverse.
HISTOPATHOLOGY: NON-NEOPLASTIC
Vacuolisation of the liver was seen in all treated and control rats. This was considered as a common finding in rats maintained at high-fat, semi-purified diets (Webb eta. 1991). Nephrocalcinosis was also seen in all rats, but there was no histopathological correlate that demonstrated a relationship to treatment.
OTHER FINDINGS
The total fat content in heart, liver and perirenal fat was comparable across all groups, i.e. feeding caprenin or MCT had no effect compared to corn oil feeding.
Behenic acid (C22:0) was not detectable in fat from heart and liver. Low quantities of C22:0 acid were only found in the perirenal fat of caprenin fed males and females in the range of 0.66 to 1.75 % of total fat. The content was higher in females, but there was no relation to dose in either sex. The observation of only trace amounts indicates that absorbed Behenic acid undergoes degradation and is not integrated as such into fat tissue.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 13 200 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: see 'Remark'
- Dose descriptor:
- NOAEL
- Effect level:
- 11.21 other: % (w/w) in diet
- Based on:
- other: MCT;
- Sex:
- male/female
- Basis for effect level:
- other: Absence of advers effects. During metabolism, MCT liberates octanoic (content 70.6%, w/w) and decanoic acid (content 25.9%, w/w).
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Applicant's summary and conclusion
- Conclusions:
- No adverse effect was seen in a subacute feeding study using male and female rats exposed to caprenin (up to 15% in diet) and MCT (11.21% in diet).
For nonanoic acid NOAEL values of >3000 and 5000 mg/kg bw and day were derived from experiments using two different types of triglycerides.Hence, the NOAEL(rat, oral feed, 90d) for nonanoic acid is set at > 3000 mg/kg bw and day. - Executive summary:
The subchronic toxicity of caprenin was examined in a 90-day feeding study in rats using a protocol that was comparable to OECD TG 408. Caprenin represents a triglyceride containing primarily C8, C10, and C22 saturated fatty acids. The dose levels were the same as those in a preceding 28-day rat study (NOAEL 15 % in diet), i.e. 5.23, 10..23, and 15.0% in diet. Control groups were fed a corn oil diet (12.4%) or a diet containing 11.21% MCT, i.e. triglycerides containing primarily C6, C8, and C10 fatty acids. For clarity, the fatty acid content of the various oils is given in table 1 below.
Table 1 Fatty acid composition of Caprein, MCT, and vehicle corn oil (% w/w)
Fatty acid
Caprenin
Corn oil
MCT
C6:0
-
-
4.5
C8:0
23.2
-
70.6
C10:0
26.6
-
25.9
C12:0
0.3
-
-
C16:0
0.2
11.3
-
C18:0
0.9
2.1
-
C18:1
-
25.4
-
C18:2
-
60.7
-
C18:3
-
0.5
-
C20:0
2.7
-
-
C22:0
45.0
-
-
C24:0
1.1
-
-
The animals received isocaloric diets during Day 1 through day 91 of the study. The fat composition is given in table 2. Content of proteins, carbohydrates, vitamin mix, minerals, fibre was comparable across the diets; for practical reasons not tabulated.
Table 2 Composition (%, w/w) of Caprenin and control diets
Ingredient
Corn oil control
MCT control
Caprenin
Low dose
Mid dose
High dose
Caprenin
-
-
5.23
10.23
15.00
Corn oil
12.14
3.13
8.96
5.91
3.00
MCT oil
-
11.21
-
-
-
Thus, all diets contained at least 3.13 % corn oil and other fatty acids from either MCT or Caprenin. Fresh diets were weekly prepared and food consumption of the animals (singly housed; 25 rats per sex and group, total of 125 male and 125 female rats) was recorded. Examinations were similar to OECD 408, urinalysis was, however, omitted, and histopathology was performed in less organs than in the OECD 408 test guideline.
The results obtained in 20 rats per sex and group indicate that no treatment-related adverse effects were noted in any of the test groups. In brief, treatment-related clinical signs and mortality were not seen; body weight development of treated groups was comparable to the corn oil controls with a slightly decreased food efficiency in the high-dose groups compared to the corn oil and MCT controls; Ophthalmoscopic examination towards the end of the study revealed no abnormalities; changes of few haematological and clinical chemistry parameters gained a level of statistical significance when compared with the corn oil or the MCT controls, but the changes were generally small, not dose-related, occurred inconsistently across sexes, or were within or close to the historical control range and were, therefore, not considered to be of toxicological relevance. Similarly, absolute and/or relative organ weight changes in liver, kidneys, spleen, heart and colon gained in some instances a level of statistical significance. Increased colon weights in Caprenin groups was attributed to a decreased absorption of the long chain Behenic acid (C22:0). The changes in the other organs were small, within the historical control range, not related to dose, or lacked a histopathological correlate and were, therefore, not considered to be adverse. The weight of the reproductive organs, testes and ovaries, were not changed in any of the treated groups.
In 5 rats per sex and group the total fat content in heart, liver, and perirenal fat was comparable across all groups, i.e. treatment with Caprenin or MCT had no influence. The concentration of Behenic acid was also examined in these fat tissues. Concentrations were undetectable in fat from heart and liver (traces in caprenin groups, below detection limit of 0.5%), whereas small amounts (0.66 to 1.75%) were detected in all male and female groups fed Caprenin. The concentrations were not related to the dose. Anyhow, this finding suggests that absorbed Behenic acid is metabolised and is not integrated into fat as such.
To conclude, no adverse effects were seen in any of the groups receiving cornoil, Caprenin, or MCT. The 90-day oral NOAEL values (rat) were therefore as follows:
NOAEL Corn oil: males and females: 12.14 % in the diet
NOAEL Caprenin: 15.0 % in the diet.
Equivalent to males: 13,200 ± 6,700 mg/kg bw and day
females: 14,600 ± 5,700 mg/kg bw and dayNOAEL MCT: males and females: 11.21 % in the diet
The study (Webb et al. 1993) is considered to be valid and useful for assessment for the target substance, nonanoic acid, in a Weight of Evidence approach because of the similarity of the medium chain fatty acids (C8, C9, C10) with regard to the absorption and metabolism in the fatty acid cycle.
It is therefore considered that the NOAEL of nonanoic acid is comparable to that of octanoic or decanoic acid. The NOAEL might also be set at the sum of the NOAELs of octanoic and decanoic acid because the rats were simultaneously exposed to both fatty acids without exerting adverse effects, and because all fatty acids must be metabolised in the fatty acid cycle. It could be mentioned that this applies also to fatty acids that are ingested in large amounts with food or feed without overt adverse effects.
On the basis of the estimated NOAEL values for octanoic (5700 mg/kg bw and day) and decanoic acid (3100 mg/kg bw and day) of the animals fed Caprenin or MCT it is concluded that the NOAEL(rat, oral feeed, 90d) for nonanoic acid is > 3000 mg/kg bw and day. The calculations are described in the attached document (Hillesheim, 2014).
Test material
Caprenin
MCT
Exposure
feed
feed
Max dose
15% in diet
11.21% in diet
NOAEL
Test material
15% in diet;
M: 13200 mg/kg bw/day
F: 14600 mg/kg bw/day11.21% in diet
M: 9865 mg/kg bw/day (estimated)
NOAEL
C8 acid (estimated)
2723 mg/kg bw/day
5704 mg/kg bw/day
NOAEL
C10 acid (estimated)
3122 mg/kg bw/day
2092 mg/kg bw/day
NOAEL
C9 acid (read across from C8 or C10 acid)
3122 mg/kg bw/day
5074 mg/kg bw/day
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.